Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-05-06Clinical Trial Update: Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples
This clinical trial update describes a Stanford-sponsored study investigating BRCA1/BRCA2-associated tumors and the collection of related tu…
-
CLINICAL_TRIALS research · 2025-05-06Clinical Trial Update: Prevention of Oral Mucositis and Improvement of Quality of Life for Patients With Breast Cancer Undergoing Adjuvant Radiotherapy [Phase 2]
A Phase 2 clinical trial sponsored by Taipei City Hospital investigates prevention of oral mucositis and quality-of-life improvements for br…
-
CLINICAL_TRIALS research · 2025-05-06Clinical Trial Update: PRECAMA: Molecular Subtypes of Premenopausal Breast Cancer in Latin American Women
This entry provides an update on the PRECAMA study, which investigates molecular subtypes of premenopausal breast cancer in Latin American w…
-
CLINICAL_TRIALS research · 2025-05-06Clinical Trial Update: The Impact of Intelligent Patient Management Model on Medication Adherence of Pyrotinib Compared to Traditional Patient Management Model: a Prospective, Multicenter, Randomized Controlled Clinical Study [Phase 2, Phase 3]
A multicenter randomized trial compares an intelligent patient management model to traditional care in improving Pyrotinib medication adhere…
-
CLINICAL_TRIALS research · 2025-05-06Clinical Trial Update: COOL-IT-PRO: Cryoablation of Breast Cancer in Non-surgical Patients
The COOL-IT-PRO trial is evaluating cryoablation for breast cancer in patients who are non-surgical candidates and is currently recruiting. …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
EMA approval · 2025-05-05EMA Authorised: Capecitabine Accord (capecitabine) — Accord Healthcare S.L.U.
The EMA authorised Capecitabine Accord (capecitabine) by Accord Healthcare S.L.U. for breast cancer, colorectal cancer, and stomach cancer, …
-
EMA approval · 2025-05-05EMA Authorised: Ecansya (previously Capecitabine Krka) (capecitabine) — Krka, d.d., Novo mesto
The EMA authorised Ecansya, a capecitabine product by Krka, as a new generic cancer treatment option for breast, colon, colorectal, and gast…
-
CLINICAL_TRIALS trial_result · 2025-05-04Clinical Trial Update: Comparing Post-operative Analgesia After (PECS II) Block and (ESPB) in Modified Radical Mastectomy [NA]
A completed clinical trial comparing PECS II block vs ESPB for post-operative analgesia after modified radical mastectomy; results posted.
-
CLINICAL_TRIALS trial_result · 2025-05-04Clinical Trial Update: Sirolimus for Injection (Albumin-bound) in Combination With Endocrine Therapy for HR+/HER2- Advanced/Metastatic Breast Cancer Patients Who Have Failed Standard Therapy [Phase 2]
Phase 2 clinical trial assessing albumin-bound sirolimus in combination with endocrine therapy for HR+/HER2- advanced/metastatic breast canc…
-
CLINICAL_TRIALS research · 2025-05-04Clinical Trial Update: Prediction of ICG for Skin Necrosis in Mastectomy With Immediate Reconstruction
A clinical trial is evaluating whether indocyanine green (ICG) imaging can predict skin necrosis after mastectomy with immediate reconstruct…
-
EMA approval · 2025-05-02EMA Authorised: Xeloda (capecitabine) — CHEPLAPHARM Arzneimittel GmbH
The EMA authorised CHEPLAPHARM Arzneimittel GmbH to market Xeloda (capecitabine) in the EU for several cancers, including breast, colon/colo…
-
CLINICAL_TRIALS trial_result · 2025-05-02Clinical Trial Update: Pilot Study of Anti-oxidant Supplementation With N-Acetyl Cysteine in Stage 0/I Breast Cancer [Phase 1]
This Phase 1 pilot study evaluated antioxidant N-acetylcysteine in patients with early-stage breast cancer around biopsy and prior to surger…
-
CLINICAL_TRIALS research · 2025-05-02Clinical Trial Update: A Phase III, Active-Controlled Study of SHR-A1811 Versus Trastuzumab Emtansine (T-DM1) in HER2-Positive Primary Breast Cancer Participants With Residual Invasive Disease Following Neoadjuvant Therapy [Phase 3]
A Phase 3 randomized, active-controlled study comparing SHR-A1811 to Trastuzumab emtansine (T-DM1) in HER2-positive primary breast cancer wi…
-
CLINICAL_TRIALS research · 2025-05-02Clinical Trial Update: Standard Surveillance vs. Intensive Surveillance in Early Breast Cancer [NA]
A clinical trial is comparing standard surveillance with intensive surveillance in patients with early breast cancer and is currently recrui…
-
CLINICAL_TRIALS withdrawal · 2025-05-02Clinical Trial Update: Investigational Drug in Combination With Two Chemotherapy Drugs in Women With Locally Recurrent or Metastatic Breast Cancer [Phase 1, Phase 2]
A phase 1/2 clinical trial of an investigational drug in combination with two chemotherapy drugs for locally recurrent or metastatic breast …
-
CLINICAL_TRIALS research · 2025-05-02Clinical Trial Update: Heart Health After Cancer Treatment (HEART-ACT) [NA]
The HEART-ACT trial investigating heart health after cancer treatment for breast cancer patients is listed as active but not recruiting, wit…
-
CLINICAL_TRIALS trial_result · 2025-05-02Clinical Trial Update: A Study of LY2880070 in Participants With Advanced or Metastatic Cancer [Phase 1, Phase 2]
Esperas Pharma completed a Phase 1/2 study of LY2880070 in adults with advanced or metastatic cancer, including colorectal cancer.
-
CLINICAL_TRIALS trial_result · 2025-05-02Clinical Trial Update: A Study of Effect of Megakaryocytes and Platelets in Breast Cancer
The Mayo Clinic-sponsored clinical trial evaluating the role of megakaryocytes and platelets in breast cancer has completed.
-
CLINICAL_TRIALS research · 2025-05-02Clinical Trial Update: A Randomized Secondary Adjuvant Treatment Intervention Study Comparing Trastuzumab-Deruxtecan to SOC Therapy in eBC Patients With Molecular Relapse [Phase 3]
Phase 3 randomized trial comparing trastuzumab-deruxtecan to standard-of-care in early breast cancer patients with molecular relapse; curren…
-
CLINICAL_TRIALS research · 2025-05-02Clinical Trial Update: Understanding and Addressing Disparities in Cancer Therapy Induced Inflammation and Associated Endothelial Dysfunction [NA]
A clinical trial update describing a study investigating disparities in cancer therapy–related inflammation and endothelial dysfunction in b…
-
CLINICAL_TRIALS research · 2025-05-02Clinical Trial Update: Quantifying Systemic Immunosuppression to Personalize Cancer Therapy
A clinical trial update describing a study to quantify systemic immunosuppression to personalize cancer therapy and that the trial is curren…
-
CLINICAL_TRIALS research · 2025-05-01Clinical Trial Update: Survival Monitoring in Russian Cancer Registries
An update on an active-not-recruiting clinical trial from N.N. Petrov National Medical Research Center of Oncology focusing on monitoring su…
-
CLINICAL_TRIALS research · 2025-05-01Clinical Trial Update: Discontinuation of CDK4/6 Inhibitors in Patients With Metastatic HR Positive, HER2 Negative Breast Cancer [Phase 2]
A Phase 2 trial update notes discontinuation of CDK4/6 inhibitors in patients with metastatic HR-positive, HER2-negative breast cancer.
-
CLINICAL_TRIALS trial_result · 2025-05-01Clinical Trial Update: Taletrectinib in Previously Treated Metastatic CDH1-mutated Invasive Lobular Cancer (ILC) [Phase 2]
A Phase 2 trial of Taletrectinib for previously treated metastatic CDH1-mutated invasive lobular breast cancer has been suspended.
-
CLINICAL_TRIALS research · 2025-05-01Clinical Trial Update: A Master Protocol Empowering Mechanobiology Translation Research in Breast Cancer
This is a master protocol study in breast cancer exploring mechanobiology translation research, currently in the recruiting stage and led by…